Volinac50 gm

Volinac is a topical (external-use) analgesic combination indicated for the short-term symptomatic relief of localized musculoskeletal pain. Its evidence-based and traditional uses include:

Established / Guideline-Supported Uses

• Relief of pain and inflammation associated with minor sprains, strains, and muscle/joint injuries.
• Symptomatic relief of localized pain due to osteoarthritis of joints amenable to topical treatment (e.g., knees, hands).
• Relief of minor backache, lumbago, and stiff neck.

Adjunct / Commonly Used (Traditional) Uses

• As an adjunct rubefacient/counterirritant for generalized muscular aches and fatigue, used alongside rest and other supportive measures rather than as sole therapy for significant injury.

Volinac is intended for short-term use on intact skin and is not a substitute for medical evaluation of persistent, severe, or worsening pain.

Diclofenac Sodium + Methyl Salicylate + Linseed Oil + Menthol is a fixed-dose topical combination. Formulations marketed under this generic name typically combine:

• Diclofenac Sodium — a non-steroidal anti-inflammatory drug (NSAID), commonly around 1% w/w.
• Methyl Salicylate — a salicylate-derived counterirritant/rubefacient, commonly in the range of 5–10% w/w.
• Linseed Oil — an emollient plant-oil base that also contributes mild anti-inflammatory and skin-conditioning properties.
• Menthol — a cooling counterirritant, commonly around 3–5% w/w.

Exact strengths of each component vary by manufacturer and dosage form (gel, cream, or liniment). Always check the product label/pack insert for the precise composition of the specific brand dispensed.

Volinac is a topical multi-ingredient preparation used for localized relief of musculoskeletal pain. It combines an NSAID (diclofenac sodium) that provides local anti-inflammatory and analgesic action with counterirritant agents (methyl salicylate and menthol) that produce a warming/cooling sensation to distract from and modulate the perception of pain, together with linseed oil as an emollient carrier that aids absorption and skin conditioning.

It is available as a topical gel, cream, or liniment for external application only and is not intended for oral, ophthalmic, or mucosal use.

Topical NSAID and counterirritant (rubefacient) combination; Volinac belongs to the class of topical analgesic preparations combining a non-steroidal anti-inflammatory agent with salicylate/menthol counterirritants.

Diclofenac Sodium + Methyl Salicylate + Linseed Oil + Menthol works through complementary local mechanisms:

• Diclofenac Sodium is a non-selective cyclooxygenase (COX-1 and COX-2) inhibitor. By blocking local prostaglandin synthesis at the site of application, it reduces inflammation, swelling, and pain in the underlying tissue.
• Methyl Salicylate is absorbed through the skin and metabolized to salicylic acid; it acts as a counterirritant, producing a mild local inflammatory/warming response that reduces the perception of deeper pain, and also contributes mild anti-inflammatory activity via the salicylate pathway.
• Menthol stimulates cutaneous cold receptors (TRPM8), producing a cooling sensation that further modulates pain perception (the "gate control" counterirritant effect).
• Linseed Oil functions primarily as an emollient vehicle that improves skin penetration of the active agents and soothes the skin surface.

Systemic absorption through intact skin is generally low relative to oral NSAID use, but absorption increases with larger application areas, prolonged use, or use under occlusion.

For topical/external use only. Wash and dry the affected area before application. Gently massage a thin layer of Volinac into clean, intact skin until absorbed. Wash hands thoroughly after application (unless the hands are the area being treated). Do not apply to broken, infected, or irritated skin, near the eyes or mucous membranes, or under occlusive dressings or heating pads.

Volinac is applied topically, and clinically significant interactions are less common than with oral NSAIDs, but the following should be noted:

• Oral NSAIDs / aspirin: Concurrent use with oral NSAIDs or aspirin may add to systemic NSAID exposure and increase the risk of gastrointestinal, renal, or bleeding-related adverse effects; avoid combining without medical guidance.
• Anticoagulants (e.g., warfarin): Salicylate absorption from methyl salicylate, combined with diclofenac's antiplatelet effect, may theoretically potentiate bleeding risk with anticoagulant therapy, especially with extensive or prolonged application.
• Other topical products: Avoid simultaneous application of other topical medicines (including other counterirritants or NSAID-containing products) to the same skin area, as this increases the risk of local irritation and systemic absorption.

Most adverse effects of Volinac are local and mild:

• Application-site reactions: redness, burning, itching, tingling, dryness, or mild rash.
• Photosensitivity of treated skin on sun exposure.
• Contact dermatitis or allergic skin reaction (uncommon).
• Systemic effects (rare with topical use, more likely with excessive application or use over large areas): gastrointestinal upset, headache, or dizziness.

Discontinue use and seek medical advice if a severe skin reaction, blistering, or signs of an allergic reaction (swelling, difficulty breathing, widespread rash) occur.

Volinac should be used in pregnancy only if clearly needed and if the potential benefit justifies the potential risk to the fetus; a physician should be consulted before use. Use is contraindicated during the third trimester due to the risk of premature closure of the ductus arteriosus associated with NSAIDs. Use during the first and second trimesters should be limited to the smallest effective area and shortest duration under medical supervision.

It is not known whether topically applied components are excreted in human breast milk in clinically significant amounts. As a precaution, breastfeeding mothers should avoid applying the product to the chest/breast area and should consult a physician before use during lactation.

The following precautions apply to Volinac:

• For external use only; avoid contact with eyes, mouth, nose, and mucous membranes, and avoid inhalation.
• Do not apply to large areas of the body, as this increases systemic absorption and the risk of NSAID-related systemic adverse effects.
• Do not use with heating pads, occlusive dressings, or tight bandages over the treated area, as this increases absorption and the risk of local skin burns/irritation.
• Avoid concurrent use of oral NSAIDs or other topical NSAID/salicylate products without medical guidance (see Interactions).
• Avoid sun exposure on treated skin due to the risk of photosensitivity.
• Use with caution in patients with a history of asthma, nasal polyps, gastrointestinal ulcer disease, renal or hepatic impairment, or bleeding disorders, given potential (though limited) systemic absorption.
• Stop use and consult a physician if symptoms worsen, persist beyond 7 days, or if signs of infection appear at the application site.

Topical overdose (excessive or too-frequent application) of Volinac may increase the risk of local skin irritation, burns, or systemic NSAID/salicylate effects such as nausea, vomiting, tinnitus, or dizziness.

Accidental oral ingestion, particularly by children, can be serious due to the salicylate and NSAID content and may cause salicylate toxicity (nausea, vomiting, rapid breathing, ringing in the ears, confusion) or NSAID toxicity (gastrointestinal bleeding, renal impairment). In case of accidental ingestion or suspected overdose, seek immediate medical attention or contact a poison control center; do not attempt home treatment.

Store at room temperature (below 30°C), away from light and moisture. Keep the container tightly closed and out of reach of children.

Renal/Hepatic impairment: Systemic absorption of Volinac is low with normal topical use, but caution is advised in patients with significant renal or hepatic impairment, especially with extensive application; avoid use over large areas in these patients.

Elderly: No specific dose adjustment is established, but elderly patients may be more susceptible to adverse effects; use the minimum effective amount.

Children: Use only per the specific product's approved age restriction (commonly not recommended below 12 years unless specifically labeled); see Pediatric Uses.

Use of Volinac should generally be limited to short-term symptomatic relief, typically not exceeding 7 days of continuous use, unless otherwise directed by a physician. Persistent pain beyond this period warrants medical evaluation.

Diclofenac Sodium + Methyl Salicylate + Linseed Oil + Menthol belongs to the topical NSAID class (diclofenac component) combined with salicylate counterirritant (methyl salicylate) and menthol counterirritant classes, formulated in an emollient (linseed oil) base — collectively categorized as a topical analgesic/rubefacient combination.

Diclofenac Sodium + Methyl Salicylate + Linseed Oil + Menthol acts through a combined local mechanism: diclofenac sodium inhibits cyclooxygenase enzymes to reduce local prostaglandin-mediated inflammation and pain; methyl salicylate is absorbed and converted to salicylic acid, producing counterirritant warming and mild anti-inflammatory effects; menthol activates cutaneous cold receptors to create a cooling counterirritant sensation that modulates pain perception; linseed oil serves as an emollient vehicle enhancing skin penetration and comfort.

Category C (first and second trimester); use is contraindicated in the third trimester, consistent with NSAID class labeling.

Safety and efficacy of Volinac in children have not been well established for most formulations. Use in children should follow the specific product's approved age restriction (commonly not recommended under 12 years of age) and should only be undertaken under the guidance of a physician. Keep out of reach of children at all times, as accidental ingestion can cause serious salicylate/NSAID toxicity.